Dose-dependent association of smoking and bronchial hyperresponsiveness

European Respiratory Journal

Volumn 42, Issue 6, 2013, Pages 1503-1512

  Juusela, Maria ^a   Pallasaho, Paula ^b   Rönmark, Eva ^c,d   Sarna, Seppo ^e   Sovijärvi, Anssi ^a   Lundbäck, Bo ^c,f  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c SUNDERBY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENVIRONMENTAL TOBACCO SMOKE; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; BRONCHUS DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; EXHALED NITRIC OXIDE FRACTION; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMAL EXPIRATORY FLOW; MIDDLE AGED; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT PARAMETERS; SMOKING; SMOKING HABIT; SPIROMETRY; STRUCTURED INTERVIEW; WHEEZING;

ADULT; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; EXHALATION; FEMALE; FINLAND; FORCED EXPIRATORY VOLUME; HISTAMINE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NITRIC OXIDE; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS; SKIN TESTS; SMOKING; SPIROMETRY; TOBACCO SMOKE POLLUTION;

EID: 84890085653     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00073712     Document Type: Article

References (33)

1. Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8: 183-192.
2. Siddiqui S, Hollins F, Saha S, et al. Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur Respir J 2007; 30: 1043-1056.
3. Schwartz J, Schindler C, Zemp E, et al. Predictors of methacholine responsiveness in a general population. Chest 2002; 122: 812-820.
4. Chinn S, Jarvis D, Luczynska CM, et al. An increase in bronchial responsiveness is associated with continuing or restarting smoking. Am J Respir Crit Care Med 2005; 172: 956-961.
5. Janson C, Chinn S, Jarvis D, et al. Effects of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet 2001; 358: 2103-2109.
6. Brutsche M, Downs S, Schindler C, et al. Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Thorax 2006; 61: 671-677.
7. Curjuric I, Zemp E, Dratva J, et al. Determinants of change in airway reactivity over 11 years in the SAPALDIA population study. Eur Respir J 2011; 37: 492-500.
8. Chinn S, Burney P, Jarvis D, et al. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1997; 10: 2495-2501.
9. Grootendorst DC, Rabe KF. Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 77-87.
10. Tønnesen P, Pisinger C, Hvidberg S, et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res 2005; 7: 139-148.
11. Piccillo G, Caponnetto P, Barton S, et al. Changes in airway hyperresponsiveness following smoking cessation: comparisons between Mch and AMP. Respir Med 2008; 102: 256-265.
12. Van den Berge M, Vonk J, Gosman M, et al. Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD. Eur Respir J 2012; 40: 1098-1105.
13. Sovijärvi AR, Malmberg LP, Reinikainen K, et al. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993; 104: 164-170.
14. Pallasaho P, Lundbäck B, Läspä SL, et al. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir Med 1999; 93: 798-809.
15. Pallasaho P, Rönmark E, Haahtela T, et al. Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland. Clin Exp Allergy 2006; 36: 503-509.
16. Viljanen AA, Haltunen PK, Kreus KE, et al. Spirometric studies in non-smoking, healthy adults. Scan J Clin Lab Invest Suppl 1982; 159: 5-20.
17. Juusela M, Pallasaho P, Sarna S, et al. Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV1, the main determinant. Clin Respir J 2013; 7: 34-44.
18. Cockroft C, Murdock K, Mink J. Determination of histamine PC20; comparison of linear and logarithmic interpolation. Chest 1983; 84: 505-506.
19. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
20. ATS/ERS recommendations for standardized procedures for the online and offline measurements of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
21. Pride NB. Assessment of changes in airway calibre I. Tests of forced expiration. Br J Clin Pharmacol 1979; 8: 193-203.
22. Nadif R, Matran R, Maccario J, et al. Passive and active smoking and exhaled nitric oxide levels according to asthma and atopy in adults. Ann Allergy Asthma Immunol 2010; 104: 385-393.
23. Grönke L, Kanniess F, Holz O, et al. The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Clin Exp Allergy 2002; 32: 57-63.
24. Rouhos A, Kainu A, Karjalainen J, et al. Atopic sensitization to common allergens without symptoms or signs of airway disorders does not increase exhaled nitric oxide. Clin Respir J 2008; 2: 141-148.
25. Kanner R, Connet J, Altose M, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 1994; 150: 956-961.
26. Prieto L, Lopez V, Llusar R, et al. Differences in the response to methacholine between the tidal breathing and dosimeter methods: influence of the dose of bronchoconstrictor agent delivered to the mouth. Chest 2008; 134: 699-703.
27. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
28. Kainu A, Lindqvist A, Sarna S, et al. FEV1 response to bronchodilation in an adult urban population. Chest 2008; 134: 387-393.
29. Jansen DF, Timens W, Kraan J, et al. (A)symptomatic bronchial hyper-responsiveness and asthma. Respir Med 1997; 91: 121-134.
30. Scichilone N, Messina M, Battaglia S, et al. Airway hyperresponsiveness in the elderly: prevalence and clinical implications. Eur Respir J 2005; 25: 364-375.
31. Chaudhuri R, Livingston E, McMahon A, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174: 127-133.
32. Pallasaho P, Juusela M, Lindqvist A, et al. Allergic rhinoconjunctivitis doubles the risk for incident asthma - results from a population study in Helsinki, Finland. Respir Med 2011; 105: 1449-1456.
33. Willemse B, Postma D, Timens W, et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23: 464-476.